News und Analysen
![KB Home Hits Peak: Pullback Imminent: https://www.marketbeat.com/logos/articles/med_20230622071816_copy-1-of-chart-kbh-6222023.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNG80YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d225c0ee3dddae3a63e185a0ba96421b09c88f23/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230622071816_copy-1-of-chart-kbh-6222023.png?locale=de)
KB Home Hits Peak: Pullback Imminent
KB Home (NYSE: KBH) reported a solid quarter and raised guidance, but the news may not be enough to keep the market moving higher. While better than expected, the results and guidance point to a
![Homebuilding Stocks Defying Cooling Housing Market: Time to Sell?: https://www.marketbeat.com/logos/articles/med_20230607142804_homebuilding-stocks-defying-cooling-housing-market.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNGNwYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--84faf964a0f7eaa10acf8a3f75c24411a1a7d176/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230607142804_homebuilding-stocks-defying-cooling-housing-market.jpg?locale=de)
Homebuilding Stocks Defying Cooling Housing Market: Time to Sell?
Despite rising mortgage rates and a slightly cooling housing market, homebuilding stocks like Lennar (NYSE: LEN) and KB Homes (NYSE: KBH) are ripping higher and outperforming the S&P 500.
The
![3 Late-Season Earnings Plays for Mid-Cap Traders: https://www.marketbeat.com/logos/articles/med_20230531075618_3-late-season-earnings-plays-for-mid-cap-traders.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBLzBmYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d0eac3c0323e773231ee2525c7ec3c10552e3a8f/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230531075618_3-late-season-earnings-plays-for-mid-cap-traders.jpg?locale=de)
3 Late-Season Earnings Plays for Mid-Cap Traders
As June rolls around, amusement parks and beachside cabanas are getting worked into the budgets of vacation-hungry Americans. For U.S. stock traders, summer’s kickoff coincides with the conclusion
![Hyku Biosciences Launches With $56M to Advance its Covalent Medicines Platform to Expand the Boundaries of Drug Discovery](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
Hyku Biosciences Launches With $56M to Advance its Covalent Medicines Platform to Expand the Boundaries of Drug Discovery
- An innovative covalent platform for precision targeting of disease-causing proteins
- Seed financing led by RA Capital Management, Droia Ventures, and Novartis Venture
![KB Home Constructs Bullish Price Action As Wider Industry Thrives](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
KB Home Constructs Bullish Price Action As Wider Industry Thrives
Key Points
- High interest rates are keeping homeowners in place, boosting homebuilders’ stocks.
- KB Home, a Los Angeles-based midcap, shows potential for further gains as it consolidates in a